Among many other financial stipulations, the CARES Act, signed into law late last month, provides $100 billion to certain healthcare providers, including O&P providers. To expedite providers getting money as quickly as possible, $30 billion is being distributed beginning TODAY, April 10, proportionate to providers’ share of Medicare fee-for-service reimbursements in 2019. All facilities and […]
As part of its ongoing efforts to provide relief during the COVID-19 Public Health Emergency (PHE), the Centers for Medicare and Medicaid Services (CMS) has expanded the Medicare Accelerated and Advanced Payment Program to temporarily increase cash flow for impacted providers. The program, which has been in existence for many years, is “intended to provide […]
This is an update to the April 2, 2020 announcement, where AOPA informed you that the Centers for Medicare and Medicaid Services (CMS) have suspended most Medicare fee-for-service medical review activity for the duration of the COVID-19 Public Health Emergency (PHE). AOPA has confirmed that CMS, effective immediately, will also not be sending out any […]
In response to the declaration of a public health emergency (PHE) due to COVID-19, the Centers for Medicare and Medicaid Services (CMS) has suspended most Medicare fee-for-service medical review activity (audits) for the duration of the PHE. The suspension of audits includes pre-payment reviews by the DME MACs under the Targeted Probe and Educate (TPE) […]
On March 30, 2020, the Centers for Medicare and Medicaid Services (CMS) announced several temporary regulatory waivers intended “to equip the American health care system with maximum flexibility to respond to the 2019 Novel Coronavirus (COVID-19) pandemic.” Included in the announcement was a notice that CMS will pause the national DMEPOS prior authorization program […]
AOPA has received questions and concerns from members about CMS guidance regarding replacement of DMEPOS during COVID-19. To address these questions and concerns, AOPA has been in contact with the DME MACs to discuss actions that they will take to implement the provisions of these emergency-based waivers. During a recent presentation the DME MACs addressed […]
Today, in response to COVID-19, Congress finalized the CARES Act, a massive financial relief package designed to tide the U.S. economy and its strained healthcare sector over for the next few months. In terms of tax relief and benefits for O&P, the bill: Carves out $350 billion in aid for small businesses, much of which […]
We have an update to yesterday’s “Guidance on Operation of O&P Businesses During State or Local Restrictions Related to COVID-19” specific to our O&P manufacturer members. AOPA has reviewed the current state and local orders and, as a general rule, there are specific exemptions that classify companies that manufacture medical devices as “essential” and therefore […]
As state and local governments begin to implement restrictions to population interaction in response to COVID-19, AOPA members have requested guidance regarding the continued operation of orthotic and prosthetic (O&P) businesses. AOPA has been monitoring developments on this issue closely and offers the following guidance based on the current available information. As of March 23, […]
On March 13, 2020, President Trump issued an emergency declaration under the Stafford Act and the National Emergencies Act to help address issues being caused by the spread of the coronavirus disease (COVID-19). As part of this declaration, the Centers for Medicare and Medicaid Services (CMS) put in place certain blanket waivers to help Medicare […]
